Cargando…

Correction to: Effect of liraglutide on cardiac function in patients with type 2 diabetes mellitus: randomized placebo-controlled trial

Detalles Bibliográficos
Autores principales:	Bizino, Maurice B., Jazet, Ingrid M., Westenberg, Jos J. M., van Eyk, Huub J., Paiman, Elisabeth H. M., Smit, Jan W. A., Lamb, Hildebrandus J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6688215/ https://www.ncbi.nlm.nih.gov/pubmed/31399033 http://dx.doi.org/10.1186/s12933-019-0905-2

Ejemplares similares

Effect of liraglutide on cardiac function in patients with type 2 diabetes mellitus: randomized placebo-controlled trial
por: Bizino, Maurice B., et al.
Publicado: (2019)

Placebo-controlled randomised trial with liraglutide on magnetic resonance endpoints in individuals with type 2 diabetes: a pre-specified secondary study on ectopic fat accumulation
por: Bizino, Maurice B., et al.
Publicado: (2019)

A double-blind, placebo-controlled, randomised trial to assess the effect of liraglutide on ectopic fat accumulation in South Asian type 2 diabetes patients
por: van Eyk, Huub J., et al.
Publicado: (2019)

Effect of Liraglutide on Cardiovascular Function and Myocardial Tissue Characteristics in Type 2 Diabetes Patients of South Asian Descent Living in the Netherlands: A Double‐Blind, Randomized, Placebo‐Controlled Trial
por: Paiman, Elisabeth H.M., et al.
Publicado: (2019)

Phenotyping diabetic cardiomyopathy in Europeans and South Asians
por: Paiman, Elisabeth H. M., et al.
Publicado: (2019)

Hepatic triglyceride content does not affect circulating CETP: lessons from a liraglutide intervention trial and a population-based cohort
por: van Eyk, Huub J., et al.
Publicado: (2019)

Differences in Inflammatory Pathways Between Dutch South Asians vs Dutch Europids With Type 2 Diabetes
por: Straat, Maaike E, et al.
Publicado: (2022)

Caloric restriction lowers endocannabinoid tonus and improves cardiac function in type 2 diabetes
por: van Eyk, Huub J., et al.
Publicado: (2018)

Sustained cardiac remodeling after a short-term very low calorie diet in type 2 diabetes mellitus
por: Jonker, Jacqueline, et al.
Publicado: (2011)

Late effects of pediatric hematopoietic stem cell transplantation on left ventricular function, aortic stiffness and myocardial tissue characteristics
por: Paiman, Elisabeth H. M., et al.
Publicado: (2019)

Long-term diet-induced, tissue-specific changes in (non)adipose triglyceride stores in obese patients with type 2 diabetes mellitus
por: Jonker, Jacqueline T, et al.
Publicado: (2011)

Aortic stiffness as an independent predictor of cardiac function and cerebral white matter hyperintensities in diabetes mellitus assessed by Magnetic Resonance Imaging
por: van Elderen, Saskia GC, et al.
Publicado: (2009)

3D free-breathing late gadolinium enhancement 3T MRI: comparison with standard 2D Imaging
por: Bizino, Maurice, et al.
Publicado: (2014)

Free-breathing 3D phase-sensitive inversion recovery late gadolinium enhancement at 3.0 Tesla: reliability and image quality in ischemic and non-ischemic cardiomyopathy in comparison with multiple breath-hold 3D imaging
por: Bizino, Maurice, et al.
Publicado: (2015)

MRI-derived cardiac mechanical dispersion for risk stratification in patients with ischemic cardiomyopathy: a preliminary study
por: Paiman, Elisabeth H, et al.
Publicado: (2016)

Correction to: Evaluating the effects of the novel GLP-1 analogue liraglutide in Alzheimer’s disease: study protocol for a randomised controlled trial (ELAD study)
por: Femminella, Grazia Daniela, et al.
Publicado: (2020)

Improvements in health‐related quality of life with liraglutide 3.0 mg compared with placebo in weight management
por: Kolotkin, R. L., et al.
Publicado: (2016)

Effect of lifestyle intervention plus rosiglitazone or placebo therapy on left ventricular mass assessed with cardiovascular magnetic resonance in the metabolic syndrome
por: Roes, Stijntje D, et al.
Publicado: (2011)

Disease duration as an indicator of the efficacy of liraglutide in patients with type 2 diabetes mellitus
por: Wilbrink, Francis J, et al.
Publicado: (2018)

Prolonged Caloric Restriction in Obese Patients With Type 2 Diabetes Mellitus Decreases Plasma CETP and Increases Apolipoprotein AI Levels Without Improving the Cholesterol Efflux Properties of HDL
por: Wang, Yanan, et al.
Publicado: (2011)

Effects of liraglutide on ANP secretion and cardiac dynamics
por: Luo, Shenghe, et al.
Publicado: (2023)

High spatial resolution free-breathing 3D late gadolinium enhancement cardiac magnetic resonance imaging in ischaemic and non-ischaemic cardiomyopathy: quantitative assessment of scar mass and image quality
por: Bizino, Maurice B., et al.
Publicado: (2018)

Correction to: Metformin and sulodexide restore cardiac microvascular perfusion capacity in diet‑induced obese rats
por: van Haare, Judith, et al.
Publicado: (2021)

Liraglutide in Type 2 Diabetes Mellitus: Clinical Pharmacokinetics and Pharmacodynamics
por: Jacobsen, Lisbeth V., et al.
Publicado: (2015)

Effectiveness of Liraglutide in Type II Diabetes Mellitus Management: Experience in Emirati Patients
por: Ghuman, Nasrullah K, et al.
Publicado: (2015)

Imaging techniques in cardiac resynchronization therapy
por: Sá, Maria Isabel, et al.
Publicado: (2007)

Effects of treatment with liraglutide on oxidative stress and cardiac natriuretic peptide levels in patients with type 2 diabetes mellitus
por: Okada, Kenta, et al.
Publicado: (2014)

The effect of hypertension on aortic pulse wave velocity in type-1 diabetes mellitus patients: assessment with MRI
por: Brandts, A., et al.
Publicado: (2011)

Efficacy and safety of liraglutide versus placebo added to basal insulin analogues (with or without metformin) in patients with type 2 diabetes: a randomized, placebo‐controlled trial
por: Ahmann, A., et al.
Publicado: (2015)

Reproducibility of native T(1) mapping for renal tissue characterization at 3T
por: Dekkers, Ilona A., et al.
Publicado: (2018)

Effects of Liraglutide Versus Placebo on Cardiovascular Events in Patients With Type 2 Diabetes Mellitus and Chronic Kidney Disease: Results From the LEADER Trial
por: Mann, Johannes F. E., et al.
Publicado: (2018)

Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+SU): a randomised controlled trial
por: Russell-Jones, D., et al.
Publicado: (2009)

Correction: Prednisolone does not improve olfactory function after COVID-19: a randomized, double-blind, placebo-controlled trial
por: Schepens, Emma J. A., et al.
Publicado: (2023)

Efficacy and Safety Comparison of Liraglutide, Glimepiride, and Placebo, All in Combination With Metformin, in Type 2 Diabetes: The LEAD (Liraglutide Effect and Action in Diabetes)-2 study
por: Nauck, Michael, et al.
Publicado: (2009)

Assessment of Aortic Pulse Wave Velocity and Cardiac Diastolic Function in Subjects With and Without the Metabolic Syndrome: HDL cholesterol is independently associated with cardiovascular function
por: Roes, Stijntje D., et al.
Publicado: (2008)

Correction to: Maternal and neonatal outcomes in mothers with diabetes mellitus in Qatari population
por: Bayoumi, Mohammad A. A., et al.
Publicado: (2021)

Correction to: Cost–Utility of Liraglutide Plus Standard of Care Versus Standard of Care in People with Type 2 Diabetes and Cardiovascular Risk in Thailand
por: Deerochanawong, Chaicharn, et al.
Publicado: (2023)

Correction: Silymarin in non-cirrhotics with non-alcoholic steatohepatitis: A randomized, double-blind, placebo controlled trial
por: Navarro, Victor J., et al.
Publicado: (2019)

Off-Label Use of Liraglutide in the Management of a Pediatric Patient with Type 2 Diabetes Mellitus
por: Micale, Sara J., et al.
Publicado: (2013)

Liraglutide Treatment Reduces Endothelial Endoplasmic Reticulum Stress and Insulin Resistance in Patients With Diabetes Mellitus
por: Bretón‐Romero, Rosa, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_lr2coo7eoagi28cvlknjkfqe58